A new study found that more than 8 in 10 people with psychiatric conditions experience harmful side effects from vaping within six hours, raising urgent concerns about e-cigarette safety in this vulnerable population. Researchers at the University of California, San Diego analyzed survey data from 851 current and former e-cigarette users with pre-existing mental health conditions and discovered that 85.3% reported at least one adverse event shortly after vaping. What Harmful Side Effects Are Psychiatric Patients Experiencing From Vaping? The study identified a range of immediate physical and psychological reactions that occur after vaping in people with mental illness. The most commonly reported side effects included coughing, anxiety, headaches, dry mouth, and lightheadedness. For individuals already managing depression, bipolar disorder, or anxiety disorders, these reactions compound an already complex clinical picture. - Coughing: Reported by 33.7% of respondents, making it the most common adverse effect - Anxiety: Experienced by 33.3% of participants, particularly troubling since anxiety was the most prevalent persistent psychiatric issue affecting 72.5% of the study group - Headache: Reported by 31.4% of respondents within six hours of vaping - Dry mouth: Affecting 28.8% of participants in the study - Lightheadedness: Reported by 25.9% of those surveyed Beyond these immediate reactions, people with multiple persistent psychiatric symptoms faced dramatically elevated risks. Those with five or more ongoing mental health issues, such as persistent anxiety, depression, sleep disturbances, and mood instability, showed more than double the odds of experiencing 19 different adverse effects. Fatigue reached an adjusted odds ratio of 4.39, and mood swings reached 3.98, meaning these individuals were nearly four times more likely to experience mood swings after vaping compared to those without persistent psychiatric symptoms. Why Are Dual Vapers at Especially High Risk? One of the most troubling findings involves the prevalence of dual vaping, where people use both nicotine and cannabis e-cigarettes simultaneously. Among the 851 respondents, 51.9% engaged in dual vaping, making it the most common vaping pattern in this population. Only 16.8% vaped nicotine alone. Dual vapers faced significantly higher odds of experiencing adverse effects. Most strikingly, they had nearly five times the odds of vomiting compared with those who vaped only nicotine or only cannabis. The simultaneous use of nicotine and cannabis through vaping is not simply two risks added together; prior research suggests that using multiple tobacco and cannabis products together increases dependence risk and amplifies harmful side effects. The U.S. Centers for Disease Control and Prevention (CDC) also notes that flavored tobacco products are more addictive than standard ones. Flavored products attract disproportionately high uptake among younger and dual-use consumers, adding yet another layer of concern for this already vulnerable population. How Should Clinicians and Patients Respond to These Vaping Risks? - Routine screening: Clinicians should routinely screen patients with psychiatric illnesses for both nicotine and cannabis vaping use during appointments and intake assessments - Patient counseling: Healthcare providers should counsel patients on the elevated risk of acute adverse effects that can occur within hours of vaping, particularly emphasizing the dangers of dual use - Integrated cessation strategies: Cessation and symptom monitoring strategies should be prioritized, especially for dual users, those with multiple physical health conditions, and those with persistent psychiatric symptoms - Targeted public health messaging: Standard public health messaging around vaping rarely distinguishes between healthy adults and those with complex mental health histories, so specific guidance and resources must reach this vulnerable population The study authors emphasize that e-cigarette adverse effects in mental health patients can no longer be a secondary concern. This population already carries a disproportionate burden of physical and psychological challenges, and vaping appears to actively worsen the very conditions many are trying to manage. People with psychiatric illnesses use tobacco and nicotine products at substantially higher rates than the general population. E-cigarettes are often marketed as a cleaner alternative to combustible cigarettes, and many in this group have adopted them widely as a result. Yet evidence on vaping risks for psychiatric patients has, until recently, remained limited. The research builds on earlier findings linking e-cigarette use to worsening mental health outcomes. A 2021 systematic review concluded that vaping was associated with greater mental health problems across multiple domains, particularly among adolescents. National surveillance data have also revealed significant associations between e-cigarette use and depression. E-cigarettes remain the most used tobacco product among young people in the United States, and vaping rates among adults with mental health conditions remain disproportionately high. These facts together make the need for targeted action and clinical attention difficult to argue against. The findings point toward a clear message: for anyone working in mental health, addiction, public health, or policy, understanding and addressing e-cigarette risks in psychiatric populations must become a priority.
